Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

NCT01893619 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-07-25

No results posted yet for this study

Summary

Observational study regarding the use of supplements in chronic fatigue syndrome patients

Conditions

  • Chronic Fatigue Syndrome

Sponsors & Collaborators

  • New York CFS Association

    lead OTHER

Principal Investigators

  • DEREK enlander · CFIDS RESEARCH FOUNDATION

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893619 on ClinicalTrials.gov